Uppdrag | 19 May 2017

Setterwalls has advised Diamyd Medical in rights issue

Responsive image

Setterwalls has acted as legal adviser to Diamyd Medical AB (publ) in connection with rights issue.

Diamyd Medical develops vaccine to considerably improve the life quality for persons with different types of diabetes and inflammatory diseases.

Contact:

Marcus Nivinger, Linnea Gävbo

Practice areas:

Equity Capital Markets

  • This field is for validation purposes and should be left unchanged.

Do you want to get in touch with us?

Please fill out the form and we will contact you as soon as possible.

Related news

The Listing Act – The European Union’s new legislative package aimed to facilitate for companies listing shares and companies acting in a listed environment

Article | 14 Nov 2024

The Listing Act – The European Union’s new legislative package aimed to facilitate for companies listing share...

Read more
Setterwalls advises Crunchfish in connection with a rights issue

Uppdrag | 06 Nov 2024

Setterwalls advises Crunchfish in connection with a rights issue

Read more
Setterwalls advised Balder in connection with directed share issue of approximately SEK 1.5 billion

Uppdrag | 04 Nov 2024

Setterwalls advised Balder in connection with directed share issue of approximately SEK 1.5 billion

Read more
Load more